UK markets closed

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
240.94+6.58 (+2.81%)
At close: 04:00PM EDT
240.94 0.00 (0.00%)
After hours: 04:30PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close234.36
Open235.32
Bid241.28 x 800
Ask250.28 x 800
Day's range234.71 - 241.45
52-week range212.40 - 317.17
Volume412,382
Avg. volume891,224
Market cap22.335B
Beta (5Y monthly)1.04
PE ratio (TTM)10.87
EPS (TTM)22.17
Earnings date27 Jul 2022 - 01 Aug 2022
Forward dividend & yield2.88 (1.20%)
Ex-dividend date18 May 2022
1y target est307.46
  • Business Wire

    Labcorp Plans Laboratory Expansion in Japan Through BML Collaboration

    BURLINGTON, N.C., June 28, 2022--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services.

  • Business Wire

    Tigerlily Foundation and Labcorp Collaborate to Increase Clinical Trial Diversity for Women of Color

    BURLINGTON, N.C. & ALDIE, Va., June 24, 2022--Labcorp, a leading global life sciences company, and Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, today announced a new collaboration to increase clinical trial diversity for women of color and co-create health equity solutions. Labcorp has signed Tigerlily’s #InclusionPledge for Black Women, joining other healthcare and life sciences companies in committing to eradicate barriers for women of color in acces

  • Zacks

    LabCorp (LH) Partners HealthVerity to Grow in Drug Development

    According to LabCorp (LH), this partnership is expected to broaden its comprehensive, end-to-end drug development and clinical trial programs.